Triphenyl bismuth | CAS#603-33-8 |

Triphenyl bismuth
featured

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 591257

CAS#: 603-33-8

Description: Triphenyl bismuth is a biochemical.

Chemical Structure

Triphenyl bismuth

CAS# 603-33-8

Instruction

Theoretical Analysis

MedKoo Cat#: 591257
Name: Triphenyl bismuth
CAS#: 603-33-8
Chemical Formula: C18H15Bi
Exact Mass: 440.10
Molecular Weight: 440.300
Elemental Analysis: C, 49.10; H, 3.43; Bi, 47.46

Price and Availability

Size	Price	Availability
5g	USD 450	2 Weeks
25g	USD 950	2 Weeks
100g	USD 1650	2 Weeks
Bulk inquiry Welcome, Customer: Please do not inquire quote if your intended use is for a patient since our products are for research use and for chemical synthesis use, not for human use . For in-stock products, we listed price in the web page. You may inquire prices for which sizes were not listed. If no price is listed, this means the product is not in stock at the moment, which may be available via custom synthesis. For cost-effective reason, minimum order of 1g is requested (typically very expensive). The lead time is usually 2-4 months. Quote of less than 1g will not be provided. MedKoo may not offer quote for below reasons: (1) current available synthetic method appears to be extremely expensive which is obviously not affordable to most customers; (2) Key raw material to make the product is temporally not available; (3) DEA controlled substances; (4) the product is under patent protection in customer’s country.

Synonym: Triphenyl bismuth; NSC 465; NSC-465; NSC465

IUPAC/Chemical Name: Bismuthine, triphenyl-

InChi Key: ZHXAZZQXWJJBHA-UHFFFAOYSA-N

InChi Code: InChI=1S/3C6H5.Bi/c3*1-2-4-6-5-3-1;/h3*1-5H;

SMILES Code: [Bi](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Instruction:

View handling instruction

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 440.30 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Mass

Concentration

Volume

M. Wt* g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Concentration 1

Volume 1

Concentration 2

Volume 2

1: Plokhikh AV, Falmbigl M, Golovina IS, Akbashev AR, Karateev IA, Presnyakov MY, Vasiliev AL, Spanier JE. Formation of BiFeO(3) from a Binary Oxide Superlattice Grown by Atomic Layer Deposition. Chemphyschem. 2017 Aug 5;18(15):1966-1970. doi: 10.1002/cphc.201700407. Epub 2017 Jun 20. PubMed PMID: 28631872.

2: Hiromori Y, Ido A, Aoki A, Kimura T, Nagase H, Nakanishi T. Ligand Activity of Group 15 Compounds Possessing Triphenyl Substituent for the RXR and PPARγ Nuclear Receptors. Biol Pharm Bull. 2016;39(10):1596-1603. PubMed PMID: 27725436.

3: Fernández J, Amestoy H, Sardon H, Aguirre M, Varga AL, Sarasua JR. Effect of molecular weight on the physical properties of poly(ethylene brassylate) homopolymers. J Mech Behav Biomed Mater. 2016 Dec;64:209-19. doi: 10.1016/j.jmbbm.2016.07.031. Epub 2016 Aug 2. PubMed PMID: 27517665.

4: Bučinský L, Jayatilaka D, Grabowsky S. Importance of Relativistic Effects and Electron Correlation in Structure Factors and Electron Density of Diphenyl Mercury and Triphenyl Bismuth. J Phys Chem A. 2016 Aug 25;120(33):6650-69. doi: 10.1021/acs.jpca.6b05769. Epub 2016 Aug 16. PubMed PMID: 27434184.

5: Goswami M, Ashley DC, Baik MH, Pohl NL. Mechanistic Studies of Bismuth(V)-Mediated Thioglycoside Activation Reveal Differential Reactivity of Anomers. J Org Chem. 2016 Jul 15;81(14):5949-62. doi: 10.1021/acs.joc.6b00860. Epub 2016 Jun 24. PubMed PMID: 27295299.

6: Weis F, Seipenbusch M, Kasper G. Film Growth Rates and Activation Energies for Core-Shell Nanoparticles Derived from a CVD Based Aerosol Process. Materials (Basel). 2015 Mar 6;8(3):966-976. doi: 10.3390/ma8030966. PubMed PMID: 28787982; PubMed Central PMCID: PMC5455439.

7: Islam A, Da Silva JG, Berbet FM, da Silva SM, Rodrigues BL, Beraldo H, Melo MN, Frézard F, Demicheli C. Novel triphenylantimony(V) and triphenylbismuth(V) complexes with benzoic acid derivatives: structural characterization, in vitro antileishmanial and antibacterial activities and cytotoxicity against macrophages. Molecules. 2014 May 12;19(5):6009-30. doi: 10.3390/molecules19056009. PubMed PMID: 24824136.

8: Berger RJ, Rettenwander D, Spirk S, Wolf C, Patzschke M, Ertl M, Monkowius U, Mitzel NW. Relativistic effects in triphenylbismuth and their influence on molecular structure and spectroscopic properties. Phys Chem Chem Phys. 2012 Nov 28;14(44):15520-4. doi: 10.1039/c2cp43471g. Epub 2012 Oct 17. PubMed PMID: 23072773.

9: Anjaneyulu O, Maddileti D, Kumara Swamy KC. Structural motifs in phenylbismuth heterocyclic carboxylates--secondary interactions leading to oligomers. Dalton Trans. 2012 Jan 21;41(3):1004-12. doi: 10.1039/c1dt11207d. Epub 2011 Nov 21. PubMed PMID: 22105914.

10: Xu H, Abdulghani S, Behiri J, Sabokbar A. Osteolytic potential of triphenyl bismuth as an alternative contrast medium in acrylic bone cement. J Biomed Mater Res B Appl Biomater. 2005 Oct;75(1):64-73. PubMed PMID: 16015616.

11: Abdulghani SN, Nazhat SN, Behiri JC, Deb S. Effect of triphenyl bismuth on glass transition temperature and residual monomer content of acrylic bone cements. J Biomater Sci Polym Ed. 2003;14(11):1229-42. PubMed PMID: 14768910.

12: Thurston JH, Whitmire KH. Molecular precursors for ferroelectric materials: synthesis and characterization of Bi2M2(mu-O)(sal)4(Hsal)4(OEt)2 and BiM4(mu-O)4(sal)4(Hsal)3(O(i)Pr)4 (sal = O2CC6H4O, Hsal = O2CC6H4OH) (M = Nb, Ta). Inorg Chem. 2003 Mar 24;42(6):2014-23. PubMed PMID: 12639136.

13: Arata T, Oyama Y, Tabaru K, Satoh M, Hayashi H, Ishida S, Okano Y. Cytotoxic effects of triphenylbismuth on rat thymocytes: comparisons with bismuth chloride and triphenyltin chloride. Environ Toxicol. 2002 Oct;17(5):472-7. PubMed PMID: 12242678.

14: Deb S, Abdulghani S, Behiri JC. Radiopacity in bone cements using an organo-bismuth compound. Biomaterials. 2002 Aug;23(16):3387-93. PubMed PMID: 12099281.

15: Lang LA, Mattie PA, Rawis HR. The effect of triphenylbismuth on the radiopacity and performance properties of compression- and injection-molded denture resins. J Prosthodont. 2000 Mar;9(1):23-9. PubMed PMID: 11074025.

16: Rawls HR, Granier RJ, Smid J, Cabasso I. Thermomechanical investigation of poly(methylmethacrylate) containing an organobismuth radiopacifying additive. J Biomed Mater Res. 1996 Jul;31(3):339-43. PubMed PMID: 8806059.

17: Mattie PA, Rawls HR, Cabasso I. Development of a radiopaque, autopolymerizing dental acrylic resin. J Prosthodont. 1994 Dec;3(4):213-8. PubMed PMID: 7866504.

18: Rawls HR, Marshall MV, Cardenas HL, Bhagat HR, Cabasso I. Cytotoxicity evaluation of a new radiopaque resin additive--triphenyl bismuth. Dent Mater. 1992 Jan;8(1):54-9. PubMed PMID: 1521685.

19: ADLOFF-BACHER M, ADLOFF JP. [ON THE LABELLING OF TRIPHENYL-BISMUTH BY RADIOACTIVE BISMUTH: CHROMATOGRAPHIC STUDY]. J Chromatogr. 1964 Jun;14:70-5. French. PubMed PMID: 14194377.

Your view history

Triphenyl bismuth featured